Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahn, P. F.
Right arrow Articles by Ferrucci, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahn, P. F.
Right arrow Articles by Ferrucci, J. T.

Radiology, Vol 174, 361-366, Copyright © 1990 by Radiological Society of North America

ARTICLES

Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors

PF Hahn, DD Stark, R Weissleder, G Elizondo, S Saini and JT Ferrucci
Department of Radiology, Harvard Medical School, Boston, MA 02114.

Previous studies of AMI-25, a particulate iron oxide magnetic resonance contrast agent, imaged liver tumors 1 or more hours after injection, in the retention phase after complete clearance of AMI-25 from the circulation. In the present study, imaging was performed in the distribution phase, during the first 12 minutes after injection while contrast agent remain in circulation, and these images were compared with those obtained in the retention phase. Nineteen patients with cancer were studied, including 15 imaged during the distribution phase. T2-weighted distribution phase images demonstrated 90% of the lesions detected by means of T2-weighted retention phase images, showed a 3.5- fold increase in contrast-to-noise ratio over images obtained before administration of AMI-25, and increased diagnostic confidence by reducing signal from small intrahepatic blood vessels. Distribution phase images showed little contrast agent uptake by cancer tissue. Both distribution and retention phase images demonstrated greater contrast agent uptake by hemangiomas than by malignant neoplasms (P less than .01). The use of both distribution phase and retention phase AMI-25- enhanced images offers improved diagnostic accuracy in the detection and characterization of focal liver lesions.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
S. M. Lee, S. H. Lee, H. Y. Kang, S. Y. Baek, S. M. Kim, and M. J. Shin
Assessment of Musculoskeletal Infection in Rats to Determine Usefulness of SPIO-Enhanced MRI
Am. J. Roentgenol., September 1, 2007; 189(3): 542 - 548.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
P Manoharan and J Ward
MRI in the assessment of focal liver lesions in the non-cirrhotic patient
Imaging, September 1, 2004; 16(4): 338 - 350.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini
Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis
Radiology, October 1, 2000; 217(1): 152 - 158.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1990 by the Radiological Society of North America.